Elevating treatment
decisions, for patients,
informed by patients
Clinical trial data uncovers multiple stories. So why listen to just one?
One2Treat offers a paradigm shift within clinical development with a unique method of evaluation of the Net Treatment Benefit
Including multiple criteria within a single primary endpoint, our approach:
- reduces sample sizes in clinical trials, cutting clinical research timelines
- connects the dots from R&D to market access,
- gives each patient access to the treatment which best meets their needs.
An already approved approach in multiple therapeutic areas, One2Treat’s solution ensures the medical need and potential of every product is explored in full. It showcases valuable additional treatment benefits to help strengthen both regulatory submission and post-regulatory market access.
Experience how our solution can revolutionize the holistic statistical assessment of your treatment.
Innovative Trial Design
Know more with less. Integrate multiple clinically relevant outcomes in your primary analysis to better leverage your data and reduce the sample size required to assess the Net Treatment Benefit.
Analyze | DEEP DIVE | Strategize
Gain in-depth understanding of your clinical trial treatment effects. Assess progress through interim futility analysis to refine strategies.
Leverage data to enhance future trial design decisions.
Benefit-Risk Assessment
Leverage quantitative evaluations for evidence-based Health Technology Assessment (HTA) and Health Economics and Outcomes Research (HEOR), strengthening your treatment market positioning and post-marketing strategy.
Patient-Centered Outcomes
Capture patient’s priorities to enable comprehensive evaluation of treatment’s effects, leading to meaningful insights that facilitate personalized decision-making.
OUR LATEST RESOURCES
